Q2 2020 Holdings
Filed 2020-08-05 | 442 holdings | $12.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $372 | 9,176 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $372 | 3,287 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $372 | 146,559 | 0.0% |
| Oaktree Specialty Lending Co | COM | 67401P108 | $372 | 83,308 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $375 | 72,378 | 0.0% |
| BlackRock Debt Strategies FD(DSU) | COM NEW | 09255R202 | $376 | 40,258 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $377 | 13,718 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $378 | 25,176 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $379 | 36,361 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $379 | 36,223 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $380 | 18,100 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $382 | 21,639 | 0.0% |
| Amyris Inc(AMRSEUR) | COM NEW | 03236M200 | $384 | 90,045 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $384 | 12,987 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $386 | 6,459 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $386 | 19,835 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $389 | 5,318 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $390 | 46,836 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $390 | 17,484 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $391 | 11,389 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $391 | 3,424 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $391 | 9,244 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $391 | 7,372 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $391 | 16,776 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $392 | 76,646 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $393 | 28,531 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $394 | 100,361 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $397 | 20,382 | 0.0% |
| Pioneer Floating Rate TR(XPHDX) | COM | 72369J102 | $398 | 41,811 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $398 | 23,281 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $399 | 12,325 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $404 | 19,310 | 0.0% |
| CEL SCI Corp(CVM1EUR) | COM PAR NEW | 150837607 | $405 | 27,116 | 0.0% |
| Bain Cap Specialty FIN Inc(BCSF) | COM STK | 05684B107 | $408 | 36,795 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $408 | 5,592 | 0.0% |
| Frequency Therapeutics Inc | COM | 35803L108 | $409 | 17,575 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $411 | 17,574 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $414 | 100,361 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $415 | 16,274 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $419 | 10,226 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $419 | 23,395 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $420 | 3,766 | 0.0% |
| Sixth Street Specialty Lendn(TSLX) | COM | 83012A109 | $421 | 25,549 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $422 | 18,899 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $422 | 39,578 | 0.0% |
| Main STR Cap Corp(MAIN) | COM | 56035L104 | $423 | 13,585 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $425 | 50,694 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $427 | 20,086 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $429 | 5,844 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $429 | 20,817 | 0.0% |